Vice President of Market Access @ Merwin Consulting (November 2016 - Present)
VP, Market Access @ (November 2018 - December 2024)
Sr. VP, Business Development @ The Access Group (March 2018 - November 2018)
Principal @ Currently Consulting - Open to Opportunity (November 2016 - October 2018)
Vice President, Commercial Operations @ QOL Medical,LLC (July 2013 - November 2016)
Sr. Director, Reimbursement and Government Affairs @ (June 2009 - July 2013)
Sr VP, Commercial Operations @ ADVENTRX Pharmaceutical Inc. (October 2007 - June 2009)
Sr. Director, Sales and Program Development @ (September 2005 - October 2007)
Director of Marketing @ (October 2003 - September 2005)
Dept Head, Reimbursement and Gov Affairs @ (November 1999 - October 2003)
Gemzar Product Manager @ Eli Lilly (January 1995 - January 1997)
Mark Erwin Education
Purdue University
Bachelor of Science (B.S.) (Chemistry)
1982-1986
Mark Erwin Skills
340B
Analytical Skills
Biopharmaceuticals
Biosimilars
Biotechnology
Budgeting & Forecasting
Business Development
Cardiology
Clinical Development
Clinical Research
Clinical Trials
Coaching & Mentoring
Commercial Insurance
Commercialization
Communication
Contract Management
Contract Negotiation
Contract Pricing
Contract Review
Critical Thinking
Dermatology
Drug Development
Endocrinology
Executive Relationships
FDA
Formulary
Global Strategy
Governmental Affairs
Group Purchasing
HCPCS
HEOR
Health Economics
Health Insurance
Health Policy
Health Technology Assessment (HTA)
Healthcare
Healthcare Industry
Healthcare Reimbursement
Hematology
Hepatology
Hospitals
IDNs
Infectious Diseases
Influencing Others
Interpersonal Skills
Leadership
Life Sciences
Lifesciences
Line Management
Managed Care
Management
Market Access
Marketing
Marketing Strategy
Medicaid
Medical Devices
Medicare
Medicare Part B
Medicare Part D
Medicare/Medicaid Reimbursement
National Accounts
Negotiation
Nephrology
Neurology
Oncology
Patient Support
Payer
Payer Relations
Performance Metrics
Pharmaceutical Industry
Pharmaceutical Sales
Pharmaceutics
Pharmacy Benefit Management
Pricing Strategy
Problem Solving
Product Launch
Rare Diseases
Real World Evidence (RWE)
Rebates
Regulatory Affairs
Regulatory Requirements
Rheumatology
Sales
Sales Force Development
Sales Leadership
Specialty Pharmaceutical
Specialty Pharmacy
Specialty distribution
Strategic Account Development
Strategic Initiatives
Strategic Management
Strategic Planning
Strategic Thinking
Strategy
Technology Transfer
U.S. Department of Defense
U.S. Health Insurance Portability and Accountability Act (HIPAA)
Urology
Value Propositions
Veterans Administration
Business Analysis
Microsoft Office
Product Development
Medical Diagnostics
Administrative Law
GI
Financial Advisory
Vascular
Consulting
Market
Channel
Surgery
Position Statements
Prognosis
Legislative Policy
Chemistry
Insurance
Territories
Vendors
Community
Phase Ii
Cost
Telemedicine
Sales Operations
Motivational Speaking
Marathon
Market Research
Revisions
Competitive Analysis
Idn
Finance
Incontinence
Budget Development
Oversight
Driving
Executive Oversight
Infusion Centers
Hospital Sales
Pharm
Worry
NDA
Australia
Ama
Sales and Marketing
Admin
Crc
Sequencing
Facilitation
Executive Administrative Assistance
Product Management
Treatment
Assessment
Injectable
Disease
Publication Planning
Cancer
C Level
Real Estate Transactions
CMC
Revenue
Design
Key Account
Public Relations
Outsourcing
Science
Calls
Corporate Actions
Therapeutic Areas
Hub
CRM
Hiring
Committees
Lung
Aid
Coordinated
Chain
PK/PD
Boston
Publications
Defense
Public Speaking
Source
Factoring
Salesforce.com
B2b
Methodology
Incentive Programs
Profit
Chemotherapy
Gastroenterology
ASP
Messaging
Networking
Physicians
3PL
Lobbying
Escalation
Foundation
Customer Satisfaction
System
Forecasting
Business Services
Cell
Offering
Tests
NextGen
Sage Act
Maaa
Internet Protocols
Ubiquitous Computing
Branding
Rare
Strategies
Attainment
Budgeting
Sales Messaging
Medicine
Testing
DTC
Training
Policy
Distributors
Customer Service
Long Term Care
Patient
Robust
Re Launch
Melanoma
Project Management
Informatics
American
CPT
Logo Design
System Monitoring
Reporting
Stakeholders
OPs
Call Centers
Commercial Real Estate
Investigation
Analysis
Campaigns
Government Pricing
Partnerships
Emergency Medicine
Reform
Promoting
Advertising Agency
Primary Care
Constraints
Handling Money
Product Marketing
Antibacterial
Calling
Promotional
Yahoo
Provision
Space
Emergent
Stroke
Nestle
Shareholders
Evaluations
Medical Education
Logistics
Applications
National Account Managers
HIPAA
Inflammatory Bowel Disease
IV
Dossiers
Landscaping
Business Operations
Active
Lead a Team
European Union
Fleet
Cost Savings
Sales Management
Partial
Stage
Hematologic Malignancies
Renal Cell Carcinoma
CMS
Value Assessment
Sales Trainings
CEOs
Genetic Testing
Erwin
Project Planning
Project
Rollout
Contractual Agreements
Automobile
House
Health Sciences
Silicon Graphics
Pharmacy
IBS
Strategic Communications
Colo
Ultra
DoD
Outpatient
Accounts Receivable
Pivotal
Identity
Retail Sales
Pricing
Co Promotion
Simple
Responsibility
Internal Audit
Therapists
Packaging
Regulations
Rems
Distribution
Practice Management
Code
Lead Development
Magazines
Portfolio
Reimbursement
Account Management
US Healthcare
Functional Leadership
Start Ups
Highly Creative
Government
Treating
Investments
South America
Diagnostics
Kol
Materials
Product Naming
Claim
E Learning
Compliance
Patient Advocacy
Phase
Inter Departmental Communication
Canada
Agents
Judges
Manufacturing
Federal Government
Strategic Marketing
Biologics
Program Development
Onboarding
Drg
Platforms
Invoicing
Nursing
Inpatient
Arranging
Cardiac
Budgets
Formulation
IR
Protocol Review
Foundations
Commercial Assessment
Meetings
Supply Chain
Political Campaigns
Expense Management
Legislation
Recruiting
Evaluation
Bridge
Performance Management
Mark Erwin Summary
Mark Erwin, based in United States, is currently a Senior Director, Market Access Strategy at Amneal Pharmaceuticals. Mark Erwin brings experience from previous roles at Merwin Consulting, Fresenius Kabi USA, The Access Group and Currently Consulting - Open to Opportunity. Mark Erwin holds a 1982 - 1986 Bachelor of Science (B.S.) in Chemistry @ Purdue University. With a robust skill set that includes 340B, Analytical Skills, Biopharmaceuticals, Biosimilars, Biotechnology and more. Mark Erwin has 3 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Mark Erwin?
Find contact details for 700 million professionals.